Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Eyenovia, Inc. (NASDAQ: EYEN).

Full DD Report for EYEN

You must become a subscriber to view this report.


Recent News from (NASDAQ: EYEN)

Eyenovia Completes Patient Enrollment in MicroStat MIST-1 Study and Enrolls First Patient in MIST-2 Study
NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) today announced that it has completed patient enrollment in its Phase III MIST-1 study and enrolled the first patient in its second Phase III study, the MIST-2 trial, for the Company’s Phase III MicroStat progr...
Source: GlobeNewswire
Date: December, 03 2018 09:00
Eyenovia Announces Conference Call and Webcast for Third Quarter 2018 Financial Results
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed medications topically to the eye, today announced that the Company will ...
Source: GlobeNewswire
Date: November, 01 2018 08:30
Eyenovia to Participate in Panel Presentation at OSN New York 2018
NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed medications topically to the eye, today announced that Dr. Sean Ianchul...
Source: GlobeNewswire
Date: September, 19 2018 08:30
Eyenovia to Present at the 20th Annual H.C. Wainwright Global Investment Conference
NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed medications topically to the eye, today announced that Dr. Sean Ianchule...
Source: GlobeNewswire
Date: August, 21 2018 07:30
Bragar Eagel & Squire, P.C. is Investigating Eyenovia, Inc. (EYEN) on Behalf of Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Eyenovia, Inc. (NASDAQ: EYEN).  Our investigation concerns whether Eyenovia has violated the federal securities laws and/or engaged in other unlawful business practices...
Source: GlobeNewswire
Date: August, 17 2018 15:39
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Eyenovia, Inc. (EYEN)
NEW YORK , Aug. 16, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eyenovia, Inc. ("Eyenovia" or the "Company") (NASDAQ: EYEN). Such investors are encouraged to obtain additional informa...
Source: PR Newswire
Date: August, 16 2018 14:08
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eyenovia, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Eyenovia, Inc. (“Eyenovia” or “the Company”) (NASDAQ: EYEN ) for violations of §§10(b) and 20(a) of the Securities ...
Source: Business Wire
Date: August, 16 2018 13:43
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eyenovia, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Eyenovia, Inc. (“Eyenovia” or “the Company”) (NASDAQ: EYEN ) for violations of §§10(b) and 20(a) of the Securities ...
Source: Business Wire
Date: August, 15 2018 18:56
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Eyenovia, Inc. - EYEN
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Eyenovia, Inc. (NASDAQ: EYEN) resulting from allegations that Eyenovia may have issued materially misleading business information to the investing public....
Source: Business Wire
Date: August, 15 2018 16:30
Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q2 2018 Results - Earnings Call Transcript
Eyenovia, Inc. (EYEN) Q2 2018 Results Earnings Conference Call August 14, 2018, 08:30 AM ET Executives Tram Bui - Investor Relations, The Ruth Group Sean Ianchulev - Chief Executive Officer and Chief Medical Officer John Gandolfo - Chief Financial Officer Analysts Scott Hen...
Source: SeekingAlpha
Date: August, 14 2018 14:51

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-085.394.985.394.7417,789
2018-05-178.508.48818.508.487,987

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-188,01714,22456.3625Short
2018-12-175,78914,62639.5802Short
2018-12-147,3219,32278.5346Short
2018-12-1313,08818,72469.8996Short
2018-12-122,1175,85436.1633Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on EYEN.


About Eyenovia, Inc. (NASDAQ: EYEN)

Logo for Eyenovia, Inc. (NASDAQ: EYEN)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: EYEN)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 09 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 09 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 30 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 30 2018
      Preliminary proxy statement providing notification matters to be brought to a vote
      Filing Type: PRE 14AFiling Source: edgar
      Filing Date: April, 10 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 02 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: April, 02 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 26 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 12 2018
      Filing by person(s) reporting owned shares of common stock in a public company >5%
      Filing Type: SC 13DFiling Source: edgar
      Filing Date: February, 21 2018

       

       


      Daily Technical Chart for (NASDAQ: EYEN)

      Daily Technical Chart for (NASDAQ: EYEN)


      Stay tuned for daily updates and more on (NASDAQ: EYEN)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: EYEN)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in EYEN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of EYEN and does not buy, sell, or trade any shares of EYEN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/